Skip to main content
Caplight Logo









Biofidelity

Biofidelity

Private
CambridgeHealthcare & Life Scienceshttps://biofidelity.com/

Last Round

VC Round

Apr 3, 2024

Total Funding Raised

$35.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biofidelity is a genomics technology company that develops and commercializes molecular diagnostic assays to improve access to precision medicine for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsprecision medicinegenomic testingliquid biopsyctDNA detectioncancer diagnosticsbiomarker detectiondiagnostic assayqPCRclinical oncologyrazor and bladesmolecular biologynext-gen sequencingNGSlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biofidelity Comparables

Compare Biofidelity with similar companies based on industry and business-model similarity.

Biofidelity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biocartis
79%
EntroGen, Inc.
78%
Roche Holding
76%

Biofidelity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 3, 2024
Series A ExtensionFeb 1, 2022
Series AAug 20, 2020
SeedSep 1, 2019

Key People

Founding team and executive leadership

Jonathan Senior

Chief Financial Officer

Executive Team

Biofidelity Investors

Notable investors and investment history

Biofidelity investors
InvestorRounds
BlueYard CapitalVC Round, Series A Extension, Series A
Longwall Venture PartnersSeries A, VC Round, Series A Extension, Seed
Octopus VenturesVC Round, Series A Extension
SBI Investment Co., Ltd.Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 278% MoM.

  • Jan 17, 2025

    Integrates Aspyre Lung assay into clinical trial services.

Biofidelity Filings

Explore SEC and related filing metadata, where available.

Biofidelity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biofidelity's valuation, stock price, and market status.

Is Biofidelity a public or private company?

Biofidelity is a private company.

What is the current stock price of Biofidelity?

Biofidelity is a private company with no public stock price. No recent secondary market data is available.

How much is Biofidelity worth (valuation)?

Valuation information for Biofidelity is not publicly available.

Can I buy Biofidelity stock?

Biofidelity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biofidelity's last funding round?

Biofidelity's most recent funding round was VC Round on April 3, 2024.

Who are the main investors in Biofidelity?

Key investors in Biofidelity include BlueYard Capital, Octopus Ventures.

Will Biofidelity IPO soon?

No public IPO plans have been announced for Biofidelity.

How can I track Biofidelity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biofidelity's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range29
Year Founded2019
Last FundingApr 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?